JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ALLO - Allogene Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary ALLO Stock
Financials
Financials ALLO Stock
Loading...
Loading...
Income Statement
Income Statement ALLO Stock
Balance Sheet
Balance Sheet ALLO Stock
Cash Flow Statement
Cash Flow Statement ALLO Stock
Loading...
Loading...
ALLO Financials - Allogene Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Allogene Therapeutics, Inc. (ALLO)
Financials
Financials of ALLO
Loading...
Loading...
Loading...
Loading...
Revenue
$0
Operating Income
$-209.315M
Net Income
$-190.886M
Share Count (Basic)
220.622669M
Operating Cash Flow
$-149.246M
Free Cash Flow
$-149.632M
Cash And Short-Term Equivalents
$51.688M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
120M
FY2021
FY2022
Revenue $USD
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-350M
-300M
-250M
-200M
Annual
Quarterly
Margins
Gross
Operating
Net
-1000000%
-500000%
0%
FY2023
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-55M
-50M
-45M
-40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
No data available